Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CABA

Cabaletta Bio Inc

May 08 • 04:00PM ET

3.88

-0.12 -3.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYTX ZURA LYEL ARQT RIGL

| Held by: VTI VXF IBB DFAS IWC PRFZ AVSC DFMC TMED DFAU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.29	Insider Own	12.43%	Shs Outstand	100.48M	Perf Week	31.97%
Market Cap	632.63M	Forward P/E	-	EPS next Y	-1.54	Insider Trans	0.66%	Shs Float	-	Perf Month	22.40%
Enterprise Value	526.13M	PEG	-	EPS next Q	-0.40	Inst Own	62.90%	Short Float	-	Perf Quarter	54.58%
Income	-167.86M	P/S	-	EPS this Y	24.23%	Inst Trans	2.74%	Short Ratio	6.59	Perf Half Y	48.66%
Sales	0.00M	P/B	3.48	EPS next Y	3.40%	ROA	-93.45%	Short Interest	19.64M	Perf YTD	77.17%
Book/sh	1.12	P/C	4.74	EPS next 5Y	10.78%	ROE	-126.98%	52W High	4.23 -8.27%	Perf Year	220.66%
Cash/sh	0.82	P/FCF	-	EPS past 3/5Y	-5.18% -7.84%	ROIC	-146.05%	52W Low	1.11 249.55%	Perf 3Y	-66.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	15.43% 8.54%	Perf 5Y	-59.46%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	1.79%	Oper. Margin	-	ATR (14)	0.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.77	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	61.79	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.77	EPS Q/Q	35.82%	SMA20	16.70%	Beta	3.19	Target Price	13.12
Payout	-	Debt/Eq	0.24	Sales Q/Q	-	SMA50	23.14%	Rel Volume	1.56	Prev Close	4.00
Employees	156	LT Debt/Eq	0.03	Earnings	Mar 23 BMO	SMA200	55.44%	Avg Volume	2.98M	Price	3.88
IPO	Oct 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.29% -	Trades		Volume	4,660,182	Change	-3.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)